Taiflex Scientific Co., Ltd.

Total Valuation

Taiflex Scientific Co., Ltd. carries a market capitalization of 36.91B, placing it among publicly traded companies globally. Its enterprise value stands at 9.97B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Taiflex Scientific Co., Ltd. currently has 256.65M shares outstanding.

Valuation Ratios

Taiflex Scientific Co., Ltd. trades at a trailing price-to-earnings ratio of 38.77. The price-to-sales ratio is 1.14, and the price-to-book ratio stands at 1.83.

Enterprise Valuation

On an enterprise value basis, Taiflex Scientific Co., Ltd. trades at an EV/EBITDA multiple of 19.23 and an EV/FCF ratio of 7.54. The EV/Sales ratio of 0.99 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.23 provides insight into valuation relative to core operating earnings.

Financial Position

Taiflex Scientific Co., Ltd. maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.44, indicating elevated leverage, while an interest coverage ratio of 21.51 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taiflex Scientific Co., Ltd. posts a return on equity of 4.73 and a return on invested capital of 3.34.

Taxes

Over the trailing twelve months, Taiflex Scientific Co., Ltd. has paid 81.40M in income taxes, reflecting an effective tax rate of 25.11.

Stock Price Statistics

Taiflex Scientific Co., Ltd.'s stock has gained approximately 214.25365% over the past 52 weeks. The 50-day moving average sits at 142.89, while the 200-day moving average is 102.36.

Income Statement

Over the trailing twelve months, Taiflex Scientific Co., Ltd. generated 10.07B in revenue and converted that into 296.00M in net income, yielding earnings per share of 0.94. EBITDA reached 518.47M, while operating income came in at 518.47M.

Balance Sheet

Taiflex Scientific Co., Ltd. holds 2.82B in cash and equivalents against 1.23B in total debt, resulting in a net debt position of -1.75B. Total book value stands at 6.27B, with working capital of 5.16B providing operational flexibility.

Cash Flow

Taiflex Scientific Co., Ltd. produced 627.23M in operating cash flow over the past twelve months. After subtracting -677.76M in capital expenditures, free cash flow totaled -50.53M - equivalent to -0.20 per share.

Margins

Taiflex Scientific Co., Ltd. operates with a gross margin of 19.14, reflecting its pricing power and cost economics. The operating margin of 5.15 and net profit margin of 2.94 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Taiflex Scientific Co., Ltd.'s most recent stock split took place on July 23, 2024 with a 200:209 split ratio.

Scores

Taiflex Scientific Co., Ltd. posts an Altman Z-Score of 2.92, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.